Disease mechanisms revealed by transcription profiling in SOD1‐G93A transgenic mouse spinal cord

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Annals of Neurology

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.1252PMID 11761470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trial of celecoxib in amyotrophic lateral sclerosis

  2006cited by this paper
• Increased expression of the pro‐inflammatory enzyme cyclooxygenase‐2 in amyotrophic lateral sclerosis

  2001cited by this paper
• Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.

  2000cited by this paper
• Inhibition of cyclooxygenase‐2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

  2000cited by this paper
• Complement C1q Is Dramatically Up-Regulated in Brain Microglia in Response to Transient Global Cerebral Ischemia1 2

  2000cited by this paper
• Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons.

  2000cited by this paper
• Metallochaperones, an Intracellular Shuttle Service for Metal Ions*

  2000cited by this paper
• Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury.

  2000cited by this paper
• Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

  2000cited by this paper
• Up-regulated production and activation of the complement system in Alzheimer's disease brain.

  1999cited by this paper
• Regulation of intracellular iron metabolism in human erythroid precursors by internalized extracellular ferritin.

  1999cited by this paper
• The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids

  1999cited by this paper
• C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis.

  1999cited by this paper
• Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

  1999cited by this paper
• From Charcot to SOD1: mechanisms of selective motor neuron death in ALS.

  1999cited by this paper
• Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1

  1998cited by this paper
• Protein Oxidative Damage in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS

  1998cited by this paper
• Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis

  1998cited by this paper
• Relationship of oxygen radical‐induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS

  1998cited by this paper
• Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins.

  1998cited by this paper
• Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

  1998cited by this paper
• Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD

  1998cited by this paper
• Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

  1998cited by this paper
• Metabolic Dysfunction in Familial, but Not Sporadic, Amyotrophic Lateral Sclerosis

  1998cited by this paper
• Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.

  1997cited by this paper
• ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

  1997cited by this paper
• Inhibition of ICE slows ALS in mice

  1997cited by this paper
• Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant.

  1997cited by this paper
• Expression of Rat Cathepsin S in Phagocytic Cells (*)

  1996cited by this paper
• Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice.

  1996cited by this paper
• Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

  1996cited by this paper
• The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.

  1996cited by this paper
• Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice

  1995cited by this paper
• An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

  1995cited by this paper
• Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.

  1995cited by this paper
• Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

  1995cited by this paper
• Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons.

  1995cited by this paper
• Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis.

  1994cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Molecular cloning of the murine homologue of CD63/ME491 and detection of its strong expression in the kidney and activated macrophages.

  1994cited by this paper
• Generation and characterization of mouse microglial cell lines.

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993influential reference
• Distribution of metallothionein in the human central nervous system

  1993cited by this paper
• Nerve Regeneration Occurs in the Absence of Apolipoprotein E in Mice

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• MT-III, a brain-specific member of the metallothionein gene family.

  1992cited by this paper
• Localization of metallothionein in the brain of rat and mouse.

  1992cited by this paper
• Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I.

  1990cited by this paper
• Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells.

  1986cited by this paper
• Expression of apolipoprotein E during nerve degeneration and regeneration.

  1986cited by this paper

• Decreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosis.

  2026cites this paper
• Distinct amyloid fibril structures formed by ALS-causing SOD1 mutants G93A and D101N

  2025cites this paper
• Use of Proteomics to Explore Biomarkers of Amyotrophic Lateral Sclerosis (ALS): Proof of Principle from Humanized SOD1 Mouse to Human ALS.

  2025cites this paper
• Copper homeostasis and cuproptosis: implications for neurodegenerative diseases

  2025cites this paper
• Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

  2023cites this paper
• Anti-Inflammatory Effects of Miyako Bidens pilosa in a Mouse Model of Amyotrophic Lateral Sclerosis and Lipopolysaccharide-Stimulated BV-2 Microglia

  2023cites this paper
• Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis

  2023cites this paper
• Retinal Ganglion Cell Loss and Microglial Activation in a SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

  2021influential citation
• [The role of sphingolipids in pathogenesis of amyotrophic lateral sclerosis].

  2021cites this paper
• Exploring Sphingolipid Implications in Neurodegeneration

  2020cites this paper
• Revisiting the role of the innate immune complement system in ALS.

  2019cites this paper
• The Role of Iron in Amyotrophic Lateral Sclerosis.

  2019cites this paper
• Complement dysregulation in the central nervous system during development and disease.

  2019cites this paper
• Oxidative stress and neurodegeneration: the involvement of iron

  2018cites this paper
• Differential contribution of microglia and monocytes in neurodegenerative diseases

  2018cites this paper
• Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis.

  2018cites this paper
• RNA-Seq Analysis of Spinal Cord Tissues from hPFN1G118V Transgenic Mouse Model of ALS at Pre-symptomatic and End-Stages of Disease

  2018cites this paper
• Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?

  2018cites this paper
• Looking for the Missing Link: Application of Copper Isotope Metallomics to Amyotrophic Lateral Sclerosis

  2018influential citation
• Assessment of metal concentrations in the SOD 1 G 93 A mouse model of 1 amyotrophic lateral sclerosis and its potential role in muscular denervation , with 2 particular focus on muscle tissue 3 4

  2018cites this paper
• hnRNP R and its main interactor, the noncoding RNA 7SK, coregulate the axonal transcriptome of motoneurons

  2018cites this paper
• Assessment of metal concentrations in the SOD1G93A mouse model of amyotrophic lateral sclerosis and its potential role in muscular denervation, with particular focus on muscle tissue

  2018cites this paper
• Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases

  2017cites this paper
• Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases

  2017cites this paper
• Longitudinal assessment of metal concentrations and copper isotope ratios in the G93A SOD1 mouse model of amyotrophic lateral sclerosis.

  2017cites this paper
• A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?

  2016cites this paper
• Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotrophic Lateral Sclerosis

  2015cites this paper
• Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression

  2015cites this paper
• Iron and Neurodegeneration: Is Ferritinophagy the Link?

  2015cites this paper
• Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration

  2015cites this paper
• Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis

  2015cites this paper
• Serum ferritin is elevated in amyotrophic lateral sclerosis patients

  2015cites this paper
• Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis

  2015cites this paper
• The genetics and spread of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Metalloporphyrins as Therapeutic Catalytic Oxidoreductants in Central Nervous System Disorders

  2014cites this paper
• Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: An in vivo MR study

  2014cites this paper
• Review: Iron metabolism and the role of iron in neurodegenerative disorders

  2014cites this paper
• Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.

  2014influential citation
• Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1G93A Amyotrophic Lateral Sclerosis mouse model

  2014cites this paper
• Análise da participação das células neuronais e não-neuronais na Esclerose Lateral Amiotrófica em camundongos transgênicos para SOD1 humana utilizando técnicas de microdissecção a laser e PCR em tempo real

  2014cites this paper
• Motor neuron disease: a chemical perspective.

  2014cites this paper
• Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: A comparison between transgenic mouse models and human patients

  2013cites this paper
• Early gene expression changes in spinal cord from SOD1G93A Amyotrophic Lateral Sclerosis animal model

  2013influential citation
• C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice

  2013cites this paper
• Multiple Routes of Motor Neuron Degeneration in ALS

  2013cites this paper
• BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels.

  2013cites this paper
• The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis

  2012cites this paper
• Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis

  2012cites this paper
• Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology

  2012cites this paper
• 2 Insights Arising from Gene Expression Profiling in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention.

  2012cites this paper
• An attempt to treat amyotrophic lateral sclerosis by intracellular copper modification using ammonium tetrathiomolybdate and/or metallothionein: Fundamentals and perspective

  2012cites this paper
• Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS

  2012cites this paper
• Insights Arising from Gene Expression Profiling in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?

  2011influential citation
• Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model

  2011cites this paper
• ApoE isoform-specific regulation of regeneration in the peripheral nervous system.

  2011cites this paper
• Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis

  2010cites this paper
• Histone deacetylation and motor neuron degeneration.

  2010cites this paper
• A Single-Dose Resveratrol Treatment in a Mouse Model of Amyotrophic Lateral Sclerosis

  2010cites this paper
• Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model.

  2010cites this paper
• Up-regulation of ferritin ubiquitination in skeletal muscle of transgenic rats bearing the G93A hmSOD1 gene mutation.

  2010cites this paper
• Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord.

  2010cites this paper
• Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.

  2010cites this paper
• The transition metals copper and iron in neurodegenerative diseases.

  2010cites this paper
• Motor neuron–immune interactions: the vicious circle of ALS

  2010cites this paper
• Mutant Superoxide Dismutase-1-caused pathogenesis in Amyotrophic Lateral Sclerosis

  2010cites this paper
• Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

  2010cites this paper
• Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant

  2009cites this paper
• Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase‐linked familial amyotrophic lateral sclerosis

  2009cites this paper
• Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice

  2009cites this paper
• Glial cells in ALS: the missing link?

  2008cites this paper
• Upregulation of cathepsin S in the aging and pathological nervous system of mice.

  2008cites this paper
• Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1

  2008cites this paper
• Current and future directions in genomics of amyotrophic lateral sclerosis.

  2008cites this paper
• Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications.

  2008cites this paper
• Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression

  2008cites this paper
• Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis

  2008cites this paper
• Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.

  2008cites this paper
• Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.

  2008cites this paper
• Enzymatic and proteomic analysis of spinal cord in a G93A ALS mouse model

  2008influential citation
• Translational therapeutic strategies in amyotrophic lateral sclerosis.

  2007cites this paper
• Role of zinc in ALS

  2007cites this paper
• Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1.

  2007cites this paper
• Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.

  2007cites this paper
• Histologic and transcriptional assessment of a mild SMA model

  2007cites this paper
• Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS

  2007cites this paper
• The role of metals and their effect on oxidative stress in amyotrophic lateral sclerosis

  2007cites this paper
• Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons

  2007cites this paper
• Gene expression assays.

  2007cites this paper
• Magnetic Resonance Microscopy and Immunohistochemistry of the CNS of the Mutant SOD Murine Model of ALS Reveals Widespread Neural Deficits

  2007cites this paper
• Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse.

  2007cites this paper
• Strategies to prevent motoneuron degeneration in models of Amyotrophic Lateral Sclerosis.

  2006cites this paper
• Informatics-assisted Protein Profiling in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis*S

  2006influential citation
• Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.

  2006cites this paper
• Red cell superoxide dismutase activity in sporadic amyotrophic lateral sclerosis.

  2006cites this paper
• Role of Iron in Neurodegenerative Disorders

  2006cites this paper
• Estrogen Action in Neuroprotection and Brain Inflammation

  2006cites this paper
• ROLE OF MICROGLIA DURING MOTONEURON REGENERATION AND DEGENERATION: RELEVANCE FOR PATHOGENESIS AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

  2006cites this paper
• The Aggresome: Proteasomes, Inclusion Bodies, and Protein Aggregation

  2006cites this paper